NASDAQ:BLCM

Bellicum Pharmaceuticals, Inc Earning Date

USA |NASDAQ |USD

BLCM Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $0.00 $-0.22 $-0.18
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $250.00K $700.00K $0.00

Bellicum Pharmaceuticals, Inc's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

BLCM Earnings Date & History Chart

BLCM Earnings & Revenue Forecast

BLCM Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 0 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 0 $0.00 $0.00 $0.00
Dec 2022 0 $0.00 $0.00 $0.00

BLCM Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.92 $-0.92 $-0.92
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-5.03 $-5.03 $-5.03
Dec 2022 0 / 0 $-2.93 $-2.93 $-2.93

BLCM Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 1 $250.00K $250.00K $250.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 1 $0.00 $0.00 $0.00
Dec 2022 1 $0.00 $0.00 $0.00

BLCM Earnings Date & Revenue History

BLCM Earnings History

|
Show More
Show More

BLCM Revenue History

|
Show More
Show More

Bellicum Pharmaceuticals, Inc Next Earnings Date & Report

BLCM Next Earnings Date & Report Preview: Sep 2021 (FQ)

BLCM's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 0 analysts, the average EPS estimation for Bellicum Pharmaceuticals, Inc's next quarterly earnings is $0.00, with a low EPS estimation of $0.00, and a high estimation of $0.00.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-1.37, the last 2 month trend is $-1.37, and the 3 month trend is $-1.37.

Based on 1 analysts, the average revenue estimation is $250.00K, with a low revenue estimation of $250.00K, and a high estimation of $250.00K.

Bellicum Pharmaceuticals, Inc Previous Earnings Dates & Reports

BLCM Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Bellicum Pharmaceuticals, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

BLCM's earnings per share (EPS) was $-0.22, beating the consensus analysts forecast of $-0.85 by 74.12%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -80.36%, and higher than the same period a year before (Jun 2020) by -97.43%.

Revenues were $700.00K.

The company reported a net income of $-2.20M.

Free cash flow for the quarter was $-7.79M , compared to $-8.29M last quarter and $-14.41M a year before.

BLCM ended the quarter with $39.00K in total debt, a decrease of -32.76% compared to the previous quarter, and a decrease of -99.86% compared to the same quarter a year before.

BLCM Previous Earnings Date & Report Recap: Dec 2020 (FY)

Bellicum Pharmaceuticals, Inc's previous annual earnings date was Mar 30, 2021 for its fiscal year ended Dec 31, 2020.

BLCM's earnings per share (EPS) was $-6.66, beating the consensus analysts forecast of $-8.70 by -23.45% , and higher than the previous year's EPS (Dec 2019) by -72.16%.

Revenues were $500.00.

The company reported a net income of $-7.72K.

Bellicum Pharmaceuticals, Inc reported a free cash flow of $-55.38M for its fiscal year, compared to $-78.09M a year ago.

The company ended the fiscal year with $825.00K in total debt, a decrease of -97.78% compared to the previous year.